Inhibiting neurotransmitter reuptake
dc.contributor.assignee | Virginia Tech Intellectual Properties, Inc. | en |
dc.contributor.assignee | Mayo Foundation for Medical Edication and Research | en |
dc.contributor.department | Chemistry | en |
dc.contributor.department | Center for Drug Discovery | en |
dc.contributor.inventor | Carlier, Paul R. | en |
dc.contributor.inventor | Richelson, Elliott | en |
dc.contributor.inventor | Fauq, Abdul H. | en |
dc.contributor.inventor | Monceaux, Christopher J. | en |
dc.date.accessed | 2019-02-15 | en |
dc.date.accessioned | 2019-02-26T22:24:02Z | en |
dc.date.available | 2019-02-26T22:24:02Z | en |
dc.date.filed | 2014-03-10 | en |
dc.date.issued | 2018-04-17 | en |
dc.description.abstract | This document relates to compounds as well as methods and materials involved in modulating neurotransmitter reuptake. For example, compounds, methods for synthesizing compounds, and methods for inhibiting neurotransmitter reuptake are provided. Specifically gamma-amino alcohol derivatives that inhibit the reuptake of neurotransmitters such as dopamine, serotonin, epinephrine or norepinephrine are provided as therapeutic agents for the treatment of depression or anxiety in a mammalian subject. | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.applicationnumber | 14776397 | en |
dc.identifier.patentnumber | 9944618 | en |
dc.identifier.uri | http://hdl.handle.net/10919/87839 | en |
dc.identifier.url | http://pimg-fpiw.uspto.gov/fdd/18/446/099/0.pdf | en |
dc.language.iso | en_US | en |
dc.publisher | United States Patent and Trademark Office | en |
dc.rights | In Copyright | en |
dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | en |
dc.subject.cpc | A61K31/138 | en |
dc.subject.cpc | C07D333/28 | en |
dc.subject.cpc | C07C211/30 | en |
dc.subject.cpc | C07C215/28 | en |
dc.subject.cpc | C07C215/30 | en |
dc.subject.cpc | C07C215/68 | en |
dc.subject.cpc | C07C217/48 | en |
dc.subject.cpc | C07C217/62 | en |
dc.subject.cpc | C07C217/64 | en |
dc.subject.cpc | C07C233/43 | en |
dc.subject.cpc | C07C235/06 | en |
dc.subject.cpc | C07C235/08 | en |
dc.subject.cpc | C07C235/14 | en |
dc.subject.cpc | C07C259/06 | en |
dc.subject.cpc | C07C323/32 | en |
dc.subject.cpc | C07D205/04 | en |
dc.subject.cpc | C07D207/12 | en |
dc.subject.cpc | C07D213/30 | en |
dc.subject.cpc | C07D213/38 | en |
dc.subject.cpc | C07D213/61 | en |
dc.subject.cpc | C07D213/64 | en |
dc.subject.cpc | C07D213/65 | en |
dc.subject.cpc | C07D215/06 | en |
dc.subject.cpc | C07D261/08 | en |
dc.subject.cpc | C07D265/06 | en |
dc.subject.cpc | C07D267/10 | en |
dc.subject.cpc | C07D271/06 | en |
dc.subject.cpc | C07D295/135 | en |
dc.subject.cpc | C07D295/185 | en |
dc.subject.cpc | C07D295/192 | en |
dc.subject.cpc | C07D317/58 | en |
dc.subject.cpc | C07D319/18 | en |
dc.subject.cpc | C07D333/20 | en |
dc.subject.cpc | C07C2601/02 | en |
dc.subject.cpc | C07C2601/04 | en |
dc.title | Inhibiting neurotransmitter reuptake | en |
dc.type | Patent | en |
dc.type.dcmitype | Text | en |
dc.type.patenttype | utility | en |
Files
Original bundle
1 - 1 of 1